A recent study in adults with EoE concluded that active disease may result in reduced elimination of budesonide via CYP3A, compared to healthy adults, suggesting a possible increased risk of AS in the EoE population [23]. The gene discussed is CYP3A4; the disease is eosinophilic esophagitis.